Factors affecting medication beliefs among patients newly prescribed oral oncolytic agents.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of psychosocial oncology"
DOI: 10.1080/07347332.2020.1855497
Abstract: BACKGROUND Prescribing oral oncolytic agents (OAs) for advanced cancers is increasing. AIMS To explore changes in medication beliefs and the effects of symptom severity, cognitive effectiveness and depressive symptoms on medication beliefs over 12 weeks. METHODS… read more here.
Keywords: cognitive effectiveness; medication beliefs; symptom severity; medication ... See more keywords
Tolerability of Highly Protein Bound Targeted Oral Oncolytic Drugs in Patients With Hypoalbuminemia: A Retrospective Analysis
Sign Up to like & getrecommendations! Published in 2020 at "Annals of Pharmacotherapy"
DOI: 10.1177/1060028020942485
Abstract: Background: Hypoalbuminemia is commonly observed in cancer patients. Given the pharmacokinetic interactions between serum proteins and protein bound medications, administration of highly protein bound targeted oral oncolytic drugs may result in elevated unbound drug levels… read more here.
Keywords: protein bound; hypoalbuminemia; tolerability; targeted oral ... See more keywords
Impact of oral oncolytic initiation on medication adherence for pre-existing comorbid chronic conditions
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Oncology Pharmacy Practice"
DOI: 10.1177/1078155219875206
Abstract: Purpose Oral oncolytics have improved survival in hematological cancers like chronic myeloid leukemia, chronic lymphocytic leukemia/small lymphocytic lymphoma, and multiple myeloma; however, it is unclear of the extent to which initiating these treatments might impact… read more here.
Keywords: pre existing; initiation; comorbid; oral oncolytic ... See more keywords
Expansion of pharmacist practice in oral oncolytic therapy with a collaborative practice agreement
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Oncology Pharmacy Practice"
DOI: 10.1177/1078155220905004
Abstract: Introduction Collaborative practice agreements have been utilized to expand pharmacist roles and improve patient care outcomes. A need to reduce the time providers spend reviewing oral oncolytic prescriptions for therapy continuation or dose adjustments was… read more here.
Keywords: practice agreement; time; collaborative practice; practice ... See more keywords
Utilizaton of patient reported outcomes measures (PROM) to characterize symptom burden and adherence associated with oral oncolytic therapy.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.27_suppl.210
Abstract: 210 Background: The use of patient reported outcome measures (PROMs) to monitor cancer treatment tolerability has been shown to positively impact outcomes. The purpose of this study was to characterize the incidence and severity of… read more here.
Keywords: therapy; patient reported; symptom; oral oncolytic ... See more keywords
Increasing compliance of an oral oncolytic program in a multi-location practice.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.27_suppl.267
Abstract: 267 Background: Over the past two decades the rise in number of oral oncolytics has significantly changed the landscape of cancer treatment. Although these medications offer patients the convenience of home administration, they pose different… read more here.
Keywords: compliance; program; cjd rcca; oncolytic program ... See more keywords
The effects of COVID-19 on new oral oncolytic treatments.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.29_suppl.102
Abstract: 102Background: Dependable and timely dispensing and delivery of oral oncolytics to patients with a new indication for therapy is a central part of modern cancer care. The COVID-19 pandemic has pres... read more here.
Keywords: effects covid; oncology; oncolytic treatments; covid new ... See more keywords
Improving oral oncolytic education in a safety-net outpatient hematology-oncology practice.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.39.28_suppl.266
Abstract: 266 Background: Oral oncolytics (OO) offer convenient administration and reduce the burden of cancer treatment, while creating particular challenges regarding safety monitoring and adherence. A baseline review of oral oncolytic education (OOE) at our safety-net… read more here.
Keywords: hematology; oral oncolytic; oncology; oncolytic education ... See more keywords
Impact of a Statewide Oral Oncolytic Initiative on Five Participating Practices.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of oncology practice"
DOI: 10.1200/jop.18.00058
Abstract: PURPOSE The shift from infusion to oral oncolytic therapy presents challenges to oncology practitioners. The purpose of this study was to describe how a statewide quality-improvement collaborative can enhance quality of care for patients receiving… read more here.
Keywords: improvement; quality; five participating; oral oncolytic ... See more keywords